Answers are grounded in this paper and cite their sources.
Cycloaddition reactions of the acyclic silylene Si(SAr i Pr4 ) 2 (Ar i Pr4 = C 6 H 3 -2,6(C 6 H 3 -2,6- i Pr 2 ) 2 ) with a variety of alkenes and alkynes were investigated. Its reactions with the alkynes phenylacetylene and diphenylacetylene and the diene 2,3-dimethyl-1,3-butadiene yielded silacycles (Ar i Pr4 S) 2 Si(CH═ CPh) ( 1 ), (Ar i Pr4 S) 2 Si(PhC═ CPh) ( 2 ), and (Ar i Pr4 S) 2 SiCH 2 CMeCMe CH 2 ( 3 ) at ambient temperature. The compounds were characterized by X-ray crystallography, 1 H, 13 C, and 29 Si NMR spectroscopy, and IR spectroscopy. No reaction was observed with more substituted alkenes such as propene, ( Z )-2-butene, tert -butylethylene, cyclopentene, 1-hexene, or the alkyne bis(trimethylsilyl)acetylene under the same reaction conditions. The germylene Ge(SAr Me6 ) 2 and stannylene Sn(SAr Me6 ) 2 (Ar Me6 = C 6 H 3 -2,6(C 6 H 2 -2,4,6-Me 3 ) 2 ) analogues of Si(SAr Me6 ) 2 displayed no reaction with ethylene. Quantum chemical calculations using model tetrylenes E(SPh) 2 (E = Si, Ge, Sn; Ph = C 6 H 5 ) show that cyclization reactions are endothermic in the case of germanium and tin derivatives but energetically favored for the silicon species.
No takes yet. Share an insight, caveat, or question.
Lips et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: